相似文献
1
Apparent KIT Ser(715) deletion in GIST mRNA is not detectable in genomic DNA and represents a previously known splice variant of KIT transcript.
Am J Pathol. 2002 Aug;161(2):739-41. doi: 10.1016/S0002-9440(10)64230-7.
2
KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?
Am J Pathol. 2002 Aug;161(2):737-8; author reply 738-9. doi: 10.1016/S0002-9440(10)64229-0.
3
A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors.
Oncogene. 2005 Jun 16;24(26):4271-80. doi: 10.1038/sj.onc.1208587.
4
[Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
Zhonghua Wai Ke Za Zhi. 2004 Feb 7;42(3):140-4.
5
Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Rev Esp Enferm Dig. 2003 Oct;95(10):688-91, 683-7.
6
Effects of loss-of-function and gain-of-function mutations of c-kit on the gastrointestinal tract.
J Gastroenterol. 2000;35 Suppl 12:75-9.
7
Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
J Pathol. 2004 Jan;202(1):80-5. doi: 10.1002/path.1487.
8
New activating mutation in GI stromal tumors.
Gastroenterology. 2003 Mar;124(3):596. doi: 10.1053/gast.2003.1240596a.
9
[Analysis of c-kit gene mutations in gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi. 2004 Feb;26(2):89-92.
10
[Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
Zhonghua Zhong Liu Za Zhi. 2002 Sep;24(5):461-4.
引用本文的文献
1
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
Br J Cancer. 2008 Sep 2;99(5):734-40. doi: 10.1038/sj.bjc.6604482. Epub 2008 Aug 19.
2
Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation.
Mol Cell Biol. 2005 Aug;25(15):6747-59. doi: 10.1128/MCB.25.15.6747-6759.2005.
本文引用的文献
1
The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors.
Am J Pathol. 2002 Jan;160(1):15-22. doi: 10.1016/S0002-9440(10)64343-X.
2
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Cancer Res. 2001 Nov 15;61(22):8118-21.
3
Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese.
Jpn J Cancer Res. 2001 May;92(5):494-8. doi: 10.1111/j.1349-7006.2001.tb01121.x.
4
Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.
Am J Pathol. 2000 Oct;157(4):1091-5. doi: 10.1016/S0002-9440(10)64623-8.
5
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.
Am J Pathol. 2000 Mar;156(3):791-5. doi: 10.1016/S0002-9440(10)64946-2.
6
Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts.
Oncogene. 1999 Sep 30;18(40):5573-81. doi: 10.1038/sj.onc.1202939.
7
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
Science. 1998 Jan 23;279(5350):577-80. doi: 10.1126/science.279.5350.577.
8
Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia.
Blood. 1993 Aug 15;82(4):1151-8.
9
Expression of the Kit and KitA receptor isoforms in human acute myelogenous leukemia.
Blood. 1994 Jan 15;83(2):476-81.
Zotero 插件